(PBYI) - Earnings & Price History

PBYI: - 122.75, $4.57B, -1.90 (-1.52%)

Sector: Healthcare - Industry: Biotechnology

Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) and PB272 (neratinib (intravenous) that are in Phase-III and Phase-II clinical trials for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, and HER2 mutation-positive solid tumors. The company is also developing PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc

Past PBYI reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-01AMC-1.9232.838.052928.9535.55-23.78%13.10%-13.80%8.40M
2017-02-28AMC-1.9238.0536.737.3536.938.91.77%1.87%3.68%787.93K
2017-02-27AMC-1.9236.737.3537.2535.4537.7-0.27%-1.48%-1.74%637.92K
2016-11-09AMC-1.9748.946.8548.747.9553.753.95%▲0.41%4.38%1.35M
2016-11-08AMC-1.9746.8540.343.241.847.57.20%▲8.45%16.25%1.39M
2016-11-07AMC-1.9740.338.7538.138.141.05-1.68%▲5.77%4.00%809.91K
2016-08-09AMC-2.1845.9546.594845.2248.843.03%-4.27%-1.37%589.77K
2016-08-08AMC-2.1846.5946.0446.7745.8547.91.59%-0.38%1.19%418.68K
2016-05-10AMC-1.9922.8921.8722.2421.8126.491.69%2.92%4.66%1.93M
2016-05-09AMC-1.9921.8724.4924.5519.7424.70.24%-10.92%-10.70%1.86M
2016-02-29AMC-1.9546.344.7845.1943.2146.780.92%2.46%3.39%797.26K
2015-11-09AMC-1.8480.6990.9489.257990-1.86%▲-9.59%-11.27%1.22M
2015-08-10AMC-1.5597.0191.6589.587.0597.91-2.35%8.39%5.85%1.01M
2015-03-02AMC-1.19206.01213.75212.75202.01214.4-0.47%-3.17%-3.62%459.21K
2014-11-11Puma Biotechnlg-1.27-1.19236.12240.35237.01234.02242.03-1.39%▲-0.38%-1.76%358.80K
2014-08-12Puma Biotechnlg-0.84-1.29248.78241.68241.65241.65250.6-0.01%2.95%2.94%186.60K
2014-05-08Puma Biotechnlg-0.52-0.6769.465.8664.1764.169.58-2.57%8.15%5.38%244.10K
2014-04-07Puma Biotechnlg-0.49-0.5780.8686.9486.2177.0589.22-0.84%-6.21%-6.99%1.10M
2013-11-13Puma Biotechnlg-0.46-0.4940.2741.9441.840.0741.92-0.33%▲-3.66%-3.98%139.30K
2013-08-13Puma Biotechnlg-0.44-0.4351.7552.6352.5151.2353.04-0.23%-1.45%-1.67%43.30K
2013-05-14Puma Biotechnlg-0.63-0.432.053131.2231.1532.090.71%2.66%3.39%190.50K
2013-03-07Puma Biotechnlg-0.75-0.7328.6727.4127.3927.0429.06-0.07%4.67%4.60%35.40K
2012-11-14Puma Biotechnlg-0.51-1.2918.5919.2119.3217.6320.50.57%▲-3.78%-3.23%94.00K
2012-08-14Puma Biotechnlg-0.35-0.7413.513.513.513.513.5200

Login | Register
Tuesday Oct 24, 2017   EST
Enter a Ticker:

Economic Calendar

Chicago Fed National Activity Index 8:30 AM ET 4-Week Bill Announcement 11:00 AM ET 3-Month Bill Auction 11:30 AM ET 6-Month Bill Auction 11:30 AM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY256.11-1.00-0.39%63,840,997

Upgrades/Downgrades